THCa is the non-activated, non-psychotropic acid form of THC. THCa is a known anti-inflammatory and provides many of the same benefits of THC but without psychotropic side effects. THCa has anti-proliferative abilities that are crucial in helping inhibit the growth of cancerous cells. It also has anti-spasmodic abilities that helps subdue muscle spasms and therefore has potential use among epileptic patients.
CBN’s primary effects are as an anti-epileptic, anti-spasmodic and reliever of intra-ocular pressure. Recent studies suggest that CBN can be administered as an antidepressant, can be used to prevent convulsions and to sedate patients experiencing pain. It is ideal for those suffering from Glaucoma, inflammation, and insomnia. CBN is often referred to as a natural aspirin or non-narcotic type pain reliever (analgesic), but is estimated to be three times stronger.
CBD has been shown effective in treating inflammation, diabetes, cancer, mood disorders (PTSD to ADD) and neurodegenerative diseases such as Alzheimer’s. It has been shown to have anti-convulsive, anti-anxiety, anti-psychotic, anti-nausea and anti-rheumatoid arthritis and sedative properties. Recent clinical trials showed that it eliminates anxiety and other unpleasant psychological side effects.
Studies conducted on CBG show it may reduce intraocular pressure and increase aqueous outflow through the ntricate mesh of drainage channels in the tissue surrounding the eye. CBG has demonstrated an anti inflammatory effect on inflammatory bowel disease. Additionally, CBG has been shown to reduce pain, ease symptoms of psoriasis, act as an antibacterial agent and even slow the proliferation of tumor cells. As a topical treatment, CBG has been shown to have anti-microbial effects and kill surface bacteria.
THC helps reduce nausea and vomiting, which is particularly helpful to patients undergoing chemotherapy for cancer. Patients suffering from AIDS often experience a lack of appetite, of which tetrahydrocannabinol is also helpful in counteracting. Found in cannabis, tetrahydrocannabinol is also sometimes used for glaucoma relief.
THCv is similar to THC, however the creation is different as it does not start out as CBGa, thus acting as an antagonist to the CB1 & CB2 receptors in the body. Given this, recent studies have shown that THCv is an excellent appetite suppressant as it blocks the rewarding sensations experienced when eating. THCv also holds anti-convulsive properties and seems to lower the seizure threshold for those with epilepsy. While psychoactive, THCv lends itself to a shorter, psychedelic, clear-headed effect which is shorter lasting that THC.
CBC, like THC and CBD, stems from CBGa. Not widely considered a well known cannabinoid, the promises of CBC are vast. CBC has been shown to inhibit the growth of cancerous tumors due to its interaction with anandamide, a human endocannabinoid that fights against cancer. It is also an inflammation and pain inhibitor and has been successful for treating migraines and stimulating bone growth. Due to its small quantity in the cannabis plant, CBC works best in conjunction with CBD and THC, thus proving that the sum is greater than the parts.
With more than 120 terpenes being identified in cannabis, we understand the impact and importance of terpenes in nutraceuticals. We strive to create the synergistic effect that comes from combining terpenes and cannabinoids for all of our products. One such important terpene is linalool, has been found to counter the anxiety and stress that some feel with THC, another is pinene, which research has proven beneficial for memory and alertness. The abundance of research and common use of aromatherapy gives us strong data to base our innovative approach and science confirms terpenes ability to work systemically with cannabinoids to increase their effectiveness. Its these unique medicinal qualities we integrate into each of our products to ensure they have the effectiveness nature intended.